EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review

Raafat Mady, Habib Tafazal, Haitham Soliman, Ayman Ramadan, Mohamed Hajaj

Cureus · 24.06.2026

DOI: 10.7759/cureus.111445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 24.06.2026. Verfasst von Raafat Mady und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Kettering General Hospital, Kettering, GBR. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

breast cancer detectionmounjaroobesity associated mammary tumortirzepatide glp-1weight-loss

Autor:innen und Institutionen

  • Department of Breast Surgery, Kettering General Hospital, Kettering, GBR.
  • Department of Breast Surgery, Blackrock Clinic, Dublin, IRL.
  • Department of Medical Oncology, Kettering General Hospital, Kettering, GBR.
  • Radiology Department, Breast Cancer Center, American Hospital, Dubai, ARE.

Zitieren

APA

Mady, R., Tafazal, H., Soliman, H., Ramadan, A., & Hajaj, M. (2026). Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.111445

Vancouver

Mady R, Tafazal H, Soliman H, Ramadan A, Hajaj M. Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus. 2026. doi:10.7759/cureus.111445

BibTeX
@article{Mady2026,
  author = {Mady, Raafat and Tafazal, Habib and Soliman, Haitham and Ramadan, Ayman and Hajaj, Mohamed},
  title = {Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.111445}
}
Kostenlos starten →